AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.

The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

COVID-19 vaccination during pregnancy was not associated with spontaneous abortion, regardless of dose number or manufacturer.

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

An AAAAI report says climate change has affected the prevalence and morbidity of allergic rhinitis, nonallergic rhinitis, and chronic rhinosinusitis.

Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.

Maternal vaccination and, to a lesser extent, nirsevimab appear to significantly reduce RSV-related hospitalizations in infants.

Mucus plugs in former smokers with COPD were associated with faster decline in FEV1 compared with no or resolved plugs.

Pediatric community-acquired pneumonia severity can be predicted accurately with 7 factors based on a new model.

RFK Jr talked about stopping NIH-funded researchers from publishing in The Lancet, New England Journal of Medicine, and JAMA.

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.